Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Revela is a consumer biotechnology company that utilizes artificial intelligence and biological screening to discover novel molecules for hair and skin health. The company's platform identifies highly effective ingredients, such as ProCelinyl for hair growth and Fibroquin for skin elasticity, which are then formulated into consumer products. Founded by a team of scientists from Harvard and MIT, Revela aims to replace traditional, less effective ingredients with scientifically validated alternatives. In May 2023, the company was acquired by Oddity for $76 million to establish Oddity Labs, integrating biotech innovation into the beauty and wellness industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Revela.